| Laura Raid Witthoeft, MD | |
|
1500 Delhi St, Suite 3100, Dubuque, IA 52001-6358 | |
| (563) 557-5959 | |
| (563) 557-5950 |
| Full Name | Laura Raid Witthoeft |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 26 Years |
| Location | 1500 Delhi St, Dubuque, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164429254 | NPI | - | NPPES |
| 0262097 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 34653 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Finley Hospital | Dubuque, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dubuque Obstetrics And Gynecology, P.c. | 2769451525 | 5 |
News Archive
Men who have been treated for colorectal cancer can reduce their risk of dying from the disease by engaging in regular exercise, according to a new study by researchers at Dana-Farber Cancer Institute. The findings are published in the December 14 issue of the Archives of Internal Medicine.
Archimedes Pharma, the leading specialty pharma company, today announced that it has raised GBP65 million (approx US$100 million) in new funding. The round was led by new investor Novo Growth Equity, the growth equity fund of Novo A/S, and included participation by major current investor, Warburg Pincus, a global private equity firm. Archimedes also announced the appointment of a new President and Chief Executive Officer, Jeffrey H. Buchalter, formerly President and Chief Executive Officer of US-based Enzon.
Cornerstone Pharmaceuticals Inc., a privately held, clinical stage oncology-focused pharmaceutical company, has announced the closing of its Series B-4 private equity financing of $6,175,000. The Company plans to use the proceeds for its on-going phase I/II clinical trials of its lead cancer drug-CPI-613, research and development, and general corporate purposes.
Cardiac Science Corporation, a global leader in automated external defibrillator and diagnostic cardiac monitoring devices, announced it has addressed outstanding issues with the Food and Drug Administration relating to the corrective AED field action announced on November 13, 2009.
Research published in the journal Clinical Science suggests that an immune signaling protein called interleukin-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms of interest for developing more effective therapy for these hard-to-treat patients.
› Verified 7 days ago
| Entity Name | Dubuque Obstetrics & Gynecology, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356370001 PECOS PAC ID: 2769451525 Enrollment ID: O20040928001135 |
News Archive
Men who have been treated for colorectal cancer can reduce their risk of dying from the disease by engaging in regular exercise, according to a new study by researchers at Dana-Farber Cancer Institute. The findings are published in the December 14 issue of the Archives of Internal Medicine.
Archimedes Pharma, the leading specialty pharma company, today announced that it has raised GBP65 million (approx US$100 million) in new funding. The round was led by new investor Novo Growth Equity, the growth equity fund of Novo A/S, and included participation by major current investor, Warburg Pincus, a global private equity firm. Archimedes also announced the appointment of a new President and Chief Executive Officer, Jeffrey H. Buchalter, formerly President and Chief Executive Officer of US-based Enzon.
Cornerstone Pharmaceuticals Inc., a privately held, clinical stage oncology-focused pharmaceutical company, has announced the closing of its Series B-4 private equity financing of $6,175,000. The Company plans to use the proceeds for its on-going phase I/II clinical trials of its lead cancer drug-CPI-613, research and development, and general corporate purposes.
Cardiac Science Corporation, a global leader in automated external defibrillator and diagnostic cardiac monitoring devices, announced it has addressed outstanding issues with the Food and Drug Administration relating to the corrective AED field action announced on November 13, 2009.
Research published in the journal Clinical Science suggests that an immune signaling protein called interleukin-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms of interest for developing more effective therapy for these hard-to-treat patients.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura Raid Witthoeft, MD 1500 Delhi St, Suite 3100, Dubuque, IA 52001-6358 Ph: (563) 557-5959 | Laura Raid Witthoeft, MD 1500 Delhi St, Suite 3100, Dubuque, IA 52001-6358 Ph: (563) 557-5959 |
News Archive
Men who have been treated for colorectal cancer can reduce their risk of dying from the disease by engaging in regular exercise, according to a new study by researchers at Dana-Farber Cancer Institute. The findings are published in the December 14 issue of the Archives of Internal Medicine.
Archimedes Pharma, the leading specialty pharma company, today announced that it has raised GBP65 million (approx US$100 million) in new funding. The round was led by new investor Novo Growth Equity, the growth equity fund of Novo A/S, and included participation by major current investor, Warburg Pincus, a global private equity firm. Archimedes also announced the appointment of a new President and Chief Executive Officer, Jeffrey H. Buchalter, formerly President and Chief Executive Officer of US-based Enzon.
Cornerstone Pharmaceuticals Inc., a privately held, clinical stage oncology-focused pharmaceutical company, has announced the closing of its Series B-4 private equity financing of $6,175,000. The Company plans to use the proceeds for its on-going phase I/II clinical trials of its lead cancer drug-CPI-613, research and development, and general corporate purposes.
Cardiac Science Corporation, a global leader in automated external defibrillator and diagnostic cardiac monitoring devices, announced it has addressed outstanding issues with the Food and Drug Administration relating to the corrective AED field action announced on November 13, 2009.
Research published in the journal Clinical Science suggests that an immune signaling protein called interleukin-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms of interest for developing more effective therapy for these hard-to-treat patients.
› Verified 7 days ago
Joseph Paul Berger, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1500 Associates Dr, Dubuque, IA 52002 Phone: 563-584-4435 Fax: 563-584-4295 | |
Teresa Eckhart, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1500 Delhi St, Suite 3100, Dubuque, IA 52001 Phone: 563-557-5959 Fax: 563-557-5950 | |
Miss Tara Leann Holste, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1500 Associates Dr, Dubuque, IA 52002 Phone: 563-584-4435 | |
Sarah Hirsch, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1500 Delhi St Ste 3100, Dubuque, IA 52001 Phone: 563-557-5959 Fax: 414-955-6528 | |
Lisa Anne Kramer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1500 Associates Dr, Dubuque, IA 52002 Phone: 563-584-4435 Fax: 563-584-4295 | |
Edward S Alt, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1500 Associates Dr, Dubuque, IA 52002 Phone: 563-584-4100 Fax: 563-584-4110 |